ClinicalTrials.gg
RecruitingNCT06204627TDCSUpdated May 16, 2024

TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain

An interventional study of TDCS and Recognize (hand) - Laterality in Neck Pain and Chronic Pain, sponsored by University of Sao Paulo General Hospital. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-16.

Sponsored by University of Sao Paulo General Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Neck Pain with a site in Brazil — 2 open to participants now, 2 under way, none of them phase 3. Neck Pain · Brazil.

Planned enrollment
5th of 22
100 · median 71
Started
2023
with 1 other
No phase
18 of 23
2 open now
Registered
17th of 23
by date
Lead sponsor
2 of 23
University of Sao Paulo General Hospital

Among the 23 studies in Neck Pain with a site in Brazil, this one is the 5th largest by planned enrollment of the 22 interventional ones that give a count, is one of 2 that started in 2023, is one of 18 with no phase, and was the 17th registered.

Neck Pain

1,367 studies on the registry are indexed under Neck Pain; 301 are open to participants now.

Browse Neck Pain studies →

Open to participants now

2 of the 23 studies in Neck Pain with a site in Brazil are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 158 Neck Pain studies recruiting now, 25 (16%) set no upper age limit and 120 (76%) stop at 75 or younger; 8 take children under 18; 27 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Neck Pain with a site in Brazil, or all of them as a file.
02

Study summary

Chronic neck pain leads to decreased quality of life and absenteeism at work, generating great personal and socio-economic impact. It has been shown that patients with chronic pain have late recognition of the laterality of the hand, which is related to the duration of symptoms and pain evoked by the execution of the movement. These findings suggest that chronic pain and the consequent disuse of certain motor functions may involve a reorganization of the cortical representation of the body scheme or motor planning.

Non-invasive neuromodulation, such as transcranial direct current stimulation (TDCS), allows modulating cortical excitability and promoting pain relief.

This study intends to verify the effects of the association of noninvasive brain stimulation with TDCS with an intervention with visual and motor stimuli related to laterality in patients with neck pain.

Read the detailed description

The study will be controlled, randomized, double-blind and will include patients with chronic neck pain, divided into four groups:

  1. active TDCS associated with laterality recognition stimuli (n = 25);
  2. active TDCS associated with landscape recognition stimuli (n = 25);
  3. TDCS sham associated with laterality recognition stimuli (n = 25);
  4. TDCS sham associated with landscape recognition stimuli (n = 25);

Eight induction sessions will be held twice a week for four weeks. Patients who present a positive response in the first reassessment (responders) will remain in the study follow-up and will undergo a weekly maintenance session, for four weeks, and two more biweekly sessions.

The following instruments will be used for evaluation: motor safety thresholds through a MagVenture pulse generator with a flat surface coil, figure 8; OPAL, device with sensors; Recognize™ application; Visual Analog Scale (VAS); Brief Pain Inventory (BDI); Clinical Global Impression - ICG (patient and evaluated version); Pain McGill Standard Questionnaire - Short Format; Hospital Anxiety and Depression Scale (HAD); 36-item summary health survey from the Medical Outcomes Study (SF-36); Mini best test; neurodynamic tests (upper limb tension tests); and quantitative sensory tests. In addition to the pre- and post-intervention assessments, there will be post-treatment follow-up performed three, six and 12 months after randomization by telephone or e-mail. It is expected that the combined application of tDCS with stimuli related to laterality will have positive effects in patients with neck pain, impacting on variables such as pain, functional movements and quality of life of these patients.

03

Conditions studied

  • Neck Pain
  • Chronic Pain

Keywords

  • chronic pain
  • neck pain
  • functional laterality
  • transcranial direct current stimulation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • participants over 18 years old;
  • pain in the cervical region, lasting more than three months and with intensity greater than 40/100 on the visual analog scale

Exclusion criteria

Exclusion Criteria:

  • history of seizures or epilepsy,
  • history of head trauma,
  • intracranial hypertension,
  • intracranial metal clip,
  • pregnant or breastfeeding women,
  • skin lesions at the current application site;
  • changes in sensitivity and allergy in the electrode positioning region.
  • intermittent pain;
  • Cancer;
  • cardiac pacemaker;
  • severe spinal diseases, such as recent fractures or ankylosing spondylitis;
  • serious cardiorespiratory diseases;
  • participants who refuse to sign the Free and Form.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Active bipolar TDCS associated with laterality recognition stimuli

    Participants will have carbon electrodes positioned, with contact through a 5x7cm sponge moistened in saline solution, with the anode on M1 and the cathode in the supra-orbital region. Individuals with active bipolar TDCS will receive a 2mA stimulus for twenty minutes. Meanwhile, they will use the Regognise hand application to discriminate right/left side of hand images.

    Device: TDCS · Device: Recognize (hand) - Laterality

  • Active comparator
    Active bipolar TDCS associated with landscape recognition stimuli

    Participants will have carbon electrodes positioned, with contact through a 5x7cm sponge moistened in saline solution, with the anode on M1 and the cathode in the supra-orbital region. Individuals with active bipolar TDCS will receive a 2mA stimulus for twenty minutes. At the same time, they will be guided to recognize landscapes that do not refer to the recognition of laterality.

    Device: TDCS · Other: Landscape recognition

  • Active comparator
    Sham TDCS associated with laterality recognition stimuli

    Participants will have carbon electrodes positioned, with contact through a 5x7cm sponge moistened in saline solution, with the anode on M1 and the cathode in the supra-orbital region. Stimulation will remain inactive for the 20 minutes. Meanwhile, they will use the Regognise hand app to discriminate right/left hand images.

    Device: Recognize (hand) - Laterality · Other: Sham TDCS

  • Placebo comparator
    Sham TDCS associated with landscape recognition stimuli

    Participants will have carbon electrodes positioned, with contact through a 5x7cm sponge moistened in saline solution, with the anode on M1 and the cathode in the supra-orbital region. Stimulation will remain inactive for the 20 minutes. At the same time, they will be guided to recognize landscapes that do not refer to the recognition of laterality.

    Other: Sham TDCS · Other: Landscape recognition

Interventions

  • DeviceTDCS

    Technique of non-invasive brain stimulation by direct current (TDCS) which involves the modulation of excitability and brain activity, capable of promoting reorganization of the cortical representation of the body schema or motor planning, and consequently, pain relief.

  • DeviceRecognize (hand) - Laterality

    This technique stimulates the ability to recognize hand images as right/left quicklPatients with chronic pain present delayed recognition of hand laterality, which is related to the duration of symptoms and the pain evoked by the execution of the movement. Thus, this technique can have beneficial effects in breaking the pain.

  • OtherSham TDCS

    TDCS sham: The device remains inactive for 20 minutes.

  • OtherLandscape recognition

    Image recognition training that does not refer to right/left discrimination.

06

What researchers measure

Primary outcomes

  1. Pain symptoms

    Change from Baseline in pain symptoms on the Visual Scale after treatment

    Time frame: up to 3 months

Secondary outcomes

  1. Clinical Global Impression

    Change from Baseline in pain severity on the Clinical Global Impression scale after treatment

    Time frame: up to 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2023 (actual). Primary completion is estimated for Aug 2024, 11 months after the start.

Of 768 non-industry interventional studies with no phase under Neck Pain, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 11 months is above that.

Counting every sponsor, half of 777 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2020
First posted
Jan 12, 2024
StartActual
Sep 30, 2023
Primary completionEst.
Aug 30, 2024
CompletionEst.
Dec 1, 2024
Last update
May 16, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06204627
Responsible party
Clarice Tanaka (Director, Principal investigator, University of Sao Paulo General Hospital) — Principal investigator
First posted
Jan 12, 2024
Start date
Sep 30, 2023
Primary completion
Aug 30, 2024 (estimated)
Completion
Dec 1, 2024 (estimated)
Last update
May 16, 2024

Study contacts

Clarice Tanaka
Contact
cltanaka@usp.br
551126616867

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion